An S3 guideline has been developed for the management of CKD in primary care. Methods: The guideline is based on publications retrieved by a systematic search of the literature for international ...

Bone disease in hypercalciuria and its interplay with the bone complications of aging-related osteoporosis and of CKD add an additional wrinkle in the proper management of these complicated patients.

The risk for emergently treated hypocalcemia in individuals receiving denosumab peaked at 2 weeks after administration and ...

For patients with chronic kidney disease (CKD), the risk for emergently treated hypocalcemia with denosumab increases with ...

Denosumab treatment for osteoporosis appears more hazardous in postmenopausal women with advanced chronic kidney disease (CKD).

"Our findings support our unwavering commitment to enhancing upstream CKD care management, preventing kidney failure and promoting health equity. We look forward to engaging with attendees on ...